₹341.1
5.5 (1.6%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 332.86 | Bullish |
| 10-DMA | 332.4 | Bullish |
| 20-DMA | 334.26 | Bullish |
| 50-DMA | 351.42 | Bearish |
| 100-DMA | 337.71 | Bullish |
| 200-DMA | 329.53 | Bullish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 36,181 | 37,249 | 28,994 | 32,521 | 30,182 |
| Total Expenditure | 31,926 | 32,475 | 24,875 | 28,156 | 25,924 |
| Other Income | 937 | 612 | 1,286 | 756 | 858 |
| Operating Profit | 5,192 | 5,387 | 5,405 | 5,121 | 5,116 |
| Interest | 634 | 630 | 501 | 377 | 348 |
| Depreciation | 1,363 | 1,305 | 1,270 | 1,212 | 947 |
| Profit Before Tax | 3,195 | 3,452 | 3,634 | 3,532 | 3,821 |
| Consolidated Net Profit | 2,367 | 3,655 | 2,725 | 2,501 | 2,957 |
| Adjusted EPS | 29 | 45 | 34 | 31 | 37 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 162 | 162 | 162 | 162 | 162 |
| Total Reserves | 32,262 | 30,470 | 29,160 | 26,888 | 23,429 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 10,908 | 9,930 | 8,807 | 8,608 | 7,545 |
| Other Current Liabilities | 1,611 | 1,720 | 1,675 | 1,953 | 1,738 |
| Short Term Borrowings | 12,072 | 4,650 | 10,432 | 541 | 4,268 |
| Total Liabilities | 58,534 | 48,946 | 54,131 | 40,791 | 40,319 |
| Capital Work in Progress | 465 | 1,859 | 1,326 | 215 | 588 |
| Long Term Loans & Advances | 3,684 | 3,084 | 3,158 | 3,682 | 2,400 |
| Currents Investments | 1,021 | --- | --- | 1,003 | 3,004 |
| Short Term Loans and Advances | 461 | 575 | 504 | 324 | 538 |
| Total Current Assets | 24,146 | 21,593 | 24,878 | 14,001 | 18,804 |
| Total Assets | 58,534 | 48,946 | 54,131 | 40,791 | 40,319 |
| Adjusted Book Value | 401 | 378 | 362 | 334 | 291 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters